Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 2002

View Archived Issues

Factor 5A gene is expressed in human heart tissue

Potential use of alefacept in scleroderma lung disease

Improved prevention of chemotherapy-induced nausea and vomiting reported for aprepitant

New assessment of palonosetron for CINV

Novel MC1 and/or MC4 receptor modulators in BMS pipeline

Telik and Sanwa describe new MCP-1 antagonists with potential in asthma and other disorders

Antibacterial compounds in early development at Daiichi

Sankyo prepares and tests new ACAT inhibitors

Novel PARP inhibitors and their use in inflammatory disorders reported by Yamanouchi

Series of SGLT-2 inhibitors designed by Kissei

Bayer researchers present novel activators of guanylate cyclase

InterLink Biotechnologies and Genome Therapeutics collaborate on antiinfective drug discovery

Third safety study for OxyTrex initiated

Genasense in combination with Rituxan evaluated in NHL patients

Promising laboratory results for phosphate-lowering RenaZorb

Orphan drug designation awarded to Neovastat in renal cell carcinoma

Celgene signs to promote Gelclair to U.S. oncology market

Largest ADHD study supports Adderall XR for improvement of symptoms and quality of life

TAP Pharmaceutical submits NDA for Uprima for ED

Effects of Enteryx on LES function in GERD patients

Rectal administration of PL-14736 safe in first human study

YH-1885 for one week significantly inhibits intragastric acidity in humans

Beneficial effects of Z-338 in patients with functional dyspepsia

Antiproliferative activity of triptolide characterized against human prostatic epithelial cells

Organ Recovery Systems cleared to market improved kidney perfusion solution

Sales of WorldHeart's Novacor LVAS continue to rise

LF-15-0195 induces long-term heart allograft survival in rat model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.